InvestorsHub Logo
Followers 3
Posts 162
Boards Moderated 0
Alias Born 03/01/2024

Re: DTGoody post# 45061

Tuesday, 03/26/2024 9:29:52 AM

Tuesday, March 26, 2024 9:29:52 AM

Post# of 47026
That is the conclusion I am coming too. Pharma is huge risk reward and only a small % of candidate drugs ever make it to the finish line. Yet, one passing through all of NIH preclinicals has better than average odds, IMO. Therefore, worth much more to the big pharma.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent RSPI News